(Q43174291)

English

Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus

scientific article published on 4 February 2010

Statements

Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus (English)
4 February 2010
2013-2018

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit